Skip to main content

Table 5 Operative complications and acetabular outliers*

From: Minimally invasive and computer-navigated total hip arthroplasty: a qualitative and systematic review of the literature

  

No. of complications

No. of outliers

Study

Methodological quality

Study group

Control group

OR (95% CI)

Study group

Control group

OR (95% CI)

MIS

       

Lawlor et al. [31]†

High

3/109

4/110

0.75 (0.16, 3.43)

  

NR

Chimento et al. [4]

High

3/28

2/32

1.80 (0.28, 11.64)

0

0

-

Ogonda et al. [34]†

High

3/109

6/110

0.75 (0.16, 3.43)

16/105

19/109

0.85 (0.41, 1.76)

Kim [30]

High

3/70

2/70

1.52 (0.25, 9.40)

13/70

11/70

1.22 (0.51, 2.95)

Chung et al. [23]

Medium

3/57

5/55

0.58 (0.13, 2.54)

0

0

-

Khan et al. [29]

Medium

15/100

21/100

0.66 (0.32, 1.38)

3/100

3/100

1.00 (0.20, 5.08)

Dorr et al. [26]

Medium

2/30

3/30

0.64 (0.10, 4.15)

0

0

-

Ciminiello et al. [24]

Medium

0

0

-

0

0

-

Dutka et al. [27]

Medium

1/60

1/60

1.00 (0.06, 16.37)

0

0

-

Hart et al. [28]

Medium

1/60

1/60

1.00 (0.06, 16.37)

0

0

-

Mazoochian et al. [37]

Medium

4/26

3/26

1.39 (0.28, 6.95)

  

NR

Rittmeister & Peters [35]

Medium

7/76

6/76

1.18 (0.38, 3.70)

  

NR

Speranza et al. [36]

Medium

3/46

0/54

8.77 (0.44, 174.38)

1/46

3/54

0.38 (0.04, 3.76)

DiGioia et al. [17]

Medium

0

0

-

0

0

-

De Beer et al. [25]

Medium

1/30

2/30

0.48 (0.04, 5.63)

0

0

-

Levine et al. [32]

Medium

14/126

13/75

0.60 (0.26, 1.35)

  

NR

Nakamura et al. [33]

Medium

1/50

2/42

0.41 (0.04, 4.67)

4/50

5/42

0.64 (0.16, 2.57)

CAS

       

Leenders et al. [16]

High

  

NR

7/50

14/50

0.42 (0.15, 1.15)

Parratte & Argenson [40]

High

0

0

-

6/30

17/30

0.19 (0.06, 0.60)

Kalteis et al. [15] (CT-based)

High

0/30

1/30

0.32 (0.01, 8.24)

5/30

16/30

0.17 (0.05, 0.58)

Kalteis et al. [15] (Imageless)

High

0/30

1/30

0.32 (0.01, 8.24)

2/30

16/30

0.06 (0.01, 0.31)

Kalteis et al. [38]

Medium

0

0

-

2/23

11/22

0.10 (0.02, 0.51)

Sugano et al. [41]

Medium

0/60

7/120

0.13 (0.01, 2.23)

0/59

31/111

0.02 (0.00, 0.36)

Najarian et al. [39]

Medium

2/47

2/53

1.13 (0.15, 8.38)

6/47

18/53

0.28 (0.10, 0.80)

Wixson & MacDonald [18]

Medium

2/82

1/50

1.23 (0.11, 13.87)

17/82

18/50

0.46 (0.21, 1.02)

  1. No. = number; OR = Odds ratio; 95% CI = 95% confidence interval; NR = outcome measure not reported. † Articles report on the same study population.
  2. * An OR below 1 with 95% CI indicates lower odds for complications and outliers in favor of the study group.